title: The right to a trial: Should dying patients have access to experimental drugs?
authors.affiliation: Harvard Medical School, Boston, MA.
authors.forename: Jerome
authors.initials: J
authors.lastname: Groopman
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000266:history; D002986:Clinical Trials as Topic / Q000191:economics / Q000941:ethics / Q000266:history / Q000331:legislation & jurisprudence / Q000379:methods / Q000592:standards / Q000706:statistics & numerical data / Q000639:trends; D017277:Drug Approval / Q000191:economics / Q000266:history / Q000331:legislation & jurisprudence / Q000379:methods / Q000706:statistics & numerical data; D004345:Drug Industry / Q000191:economics / Q000941:ethics / Q000266:history / Q000331:legislation & jurisprudence / Q000379:methods / Q000592:standards / Q000639:trends; D004992:Ethics, Medical / Q000266:history; D004994:Ethics, Pharmacy / Q000266:history; D032984:Ethics, Research / Q000266:history; D049673:History, 20th Century; D049674:History, 21st Century; D007880:Legislation, Drug / Q000941:ethics / Q000266:history / Q000592:standards / Q000706:statistics & numerical data / Q000639:trends; D009369:Neoplasms / Q000188:drug therapy; D004364:Pharmaceutical Preparations / Q000191:economics / Q000266:history / Q000592:standards; D012106:Research / Q000266:history / Q000331:legislation & jurisprudence / Q000639:trends; D012107:Research Design; D014481:United States; D014486:United States Food and Drug Administration / Q000941:ethics / Q000266:history / Q000331:legislation & jurisprudence / Q000592:standards / Q000706:statistics & numerical data / Q000639:trends; D000078329:Workforce
chemical_list: D004364:Pharmaceutical Preparations